Novo Nordisk A/S (NVO)
Q2 2012 Earnings Call
August 13, 2012 7:00 am ET
Mads Krogsgaard Thomsen - Chief Science Officer, Executive Vice President and Member of the Senior Management Board
Lars Rebien Sørensen - Chief Executive Officer, President and Member of the Senior Management Board
Kåre Schultz - Chief Operating Officer, Executive Vice President and Member of the Senior Management Board
Jesper Brandgaard - Chief Financial Officer, Executive Vice President, Member of the Senior Management Board, Chairman of Novo Nordisk Engineering A/S and Chairman of Novo Nordisk IT A/S
Brian Bourdot - Barclays Capital, Research Division
Mads Krogsgaard Thomsen
So Lars, thank you very much and the rest of the team. It's my pleasure, as I said, to introduce all of you without much further ado, I'm going to hand over the mic to Lars Sørensen to make some opening comments on the quarter and also what hope we get over the second half of this year. Lars, all yours.
Lars Rebien Sørensen
Thank you. How do I move? So thank you very much and thanks for the invitation. We've been kind of dreading coming over here not because of the results, but because of the Olympics. As it turned out, it was very quiet this morning and almost sort of silent. So we have prepared ourselves to fight through the city, but that didn't occur, so -- and the weather has been nice. So thank you very much for that. I'm just going to say a few words of introduction and then we will get on with the program. You'll get a little bit more extensive update by Kåre Schultz, Chief Financial Officer, sitting over there; and Mads Krogsgaard will be giving you an update on R&D; and Jesper Brandgaard is here. He's just out for the moment, and then we will enable the Q&A, which we'll take a seat at the table, and hope that works out.